Neurology

Hospitalisation for COVID-19 predicts long lasting cerebrovascular impairment: A prospective observational cohort study

This article's authors
1. Kamen A Tsvetanov
2. Lennart R B Spindler
3. Emmanuel A Stamatakis
4. Virginia FJ Newcombe
5. Victoria C Lupson
6. Doris A Chatfield
7. Anne E Manktelow
8. Joanne G Outtrim
9. Anne Elmer
10. Nathalie Kingston
11. John R Bradley
12. Edward T Bullmore
13. James B Rowe
14. David K Menon
15. The Cambridge NeuroCOVID Group
16. The NIHR COVID-19 BioResource
17. The Cambridge NIHR Clinical Research Facility
18. The CITIID-NIHR BioResource COVID-19 Collaboration
This article has 1 evaluations Latest evaluation on Feb 5, 2022 Published on Feb 2, 2022
Breakthrough SARS-CoV-2 infections in MS patients on disease modifying therapies

This article's authors
1. Irene Schiavetti
2. Cinzia Cordioli
3. Maria Laura Stromillo
4. Maria Teresa Ferrò
5. Alice Laroni
6. Eleonora Cocco
7. Gaia Cola
8. Livia Pasquali
9. Maria Teresa Rilla
10. Elisabetta Signoriello
11. Rosa Iodice
12. Alessia Di Sapio
13. Roberta Lanzillo
14. Francesca Caleri
15. Pietro Annovazzi
16. Antonella Conte
17. Giuseppe Liberatore
18. Francesca Ruscica
19. Renato Docimo
20. Simona Bonavita
21. Monica Ulivelli
22. Paola Cavalla
23. Francesco Patti
24. Diana Ferraro
25. Marinella Clerico
26. Paolo Immovilli
27. Massimiliano Di Filippo
28. Marco Salvetti
29. Maria Pia Sormani
30. the “Breakthrough infections in MS” study group
This article has 1 evaluations Latest evaluation on Feb 2, 2022 Published on Jan 31, 2022
Correlation between leukocyte phenotypes and prognosis of amyotrophic lateral sclerosis: a longitudinal cohort study

This article's authors
1. Can Cui
2. Caroline Ingre
3. Li Yin
4. Xia Li
5. John Andersson
6. Christina Seitz
7. Nicolas Ruffin
8. Yudi Pawitan
9. Fredrik Piehl
10. Fang Fang
This article has 4 evaluations Latest evaluation on Feb 2, 2022 Published on Oct 7, 2021
Persistently reduced humoral and cellular immune response following third SARS-CoV-2 mRNA vaccination in anti-CD20-treated multiple sclerosis patients

This article's authors
1. Hamza Mahmood Bajwa
2. Frederik Novak
3. Anna Christine Nilsson
4. Christian Nielsen
5. Dorte K. Holm
6. Kamilla Østergaard
7. Agnes Hauschultz Witt
8. Keld-Erik Byg
9. Isik S. Johansen
10. Kristen Mittl
11. William Rowles
12. Scott S. Zamvil
13. Riley Bove
14. Joseph J. Sabatino
15. Tobias Sejbaek
This article has 1 evaluations Latest evaluation on Feb 1, 2022 Published on Jan 28, 2022
SARS-CoV-2 third vaccine immune response in MS patients treated with ocrelizumab

This article's authors
1. Livnat Brill
2. Catarina Raposo
3. Ariel Rechtman
4. Omri Zveik
5. Netta Levin
6. Esther Oiknine-Djian
7. Dana G. Wolf
8. Adi Vaknin-Dembinsky
This article has 1 evaluations Latest evaluation on Feb 1, 2022 Published on Jan 28, 2022
Post-COVID-19 Memory Complaints: Prevalence and Associated Factors

This article's authors
1. Mashrur Ahmed
2. Simanta Roy
3. Sreshtha Chowdhury
4. Mohammad Azmain Iktidar
5. Sharmin Akhter
6. A. M. Khairul Islam
7. Mohammad Delwer Hossain Hawlader
This article has 1 evaluations Latest evaluation on Jan 28, 2022 Published on Feb 17, 2022
Mapping dopaminergic projections in the human brain with resting-state fMRI

This article's authors
1. Marianne Oldehinkel
2. Alberto Llera
3. Myrthe Faber
4. Ismael Huertas
5. Jan K. Buitelaar
6. Bastiaan R. Bloem
7. Andre F. Marquand
8. Rick C. Helmich
9. Koen V. Haak
10. Christian F. Beckmann
This article has 6 evaluations Latest evaluation on Jan 25, 2022 Published on Mar 26, 2021
Longitudinal prediction of motor dysfunction after stroke: a disconnectome study

This article's authors
1. Lilit Dulyan
2. Lia Talozzi
3. Valentina Pacella
4. Maurizio Corbetta
5. Stephanie J Forkel
6. Michel Thiebaut de Schotten
This article has 2 evaluations Latest evaluation on Mar 30, 2022 Published on Oct 3, 2022
Prognostic Value of Serum/Plasma Neurofilament Light Chain for COVID-19 Associated Mortality

This article's authors
1. Ruturaj R. Masvekar
2. Peter Kosa
3. Kimberly Jin
4. Kerry Dobbs
5. Michael A. Stack
6. Riccardo Castagnoli
7. Virginia Quaresima
8. Helen C. Su
9. Luisa Imberti
10. Luigi D. Notarangelo
11. Bibiana Bielekova
This article has 1 evaluations Latest evaluation on Jan 18, 2022 Published on Jan 14, 2022
Cellular and humoral immunity to SARS-CoV-2 infection in multiple sclerosis patients on ocrelizumab and other disease-modifying therapies: a multi-ethnic observational study

This article's authors
1. Ilya Kister
2. Yury Patskovsky
3. Ryan Curtin
4. Jinglan Pei
5. Katherine Perdomo
6. Zoe Rimler
7. Iryna Voloshyna
8. Marie I. Samanovic
9. Amber R. Cornelius
10. Yogambigai Velmurugu
11. Samantha Nyovanie
12. Joseph Kim
13. Ethan Tardio
14. Tamar E. Bacon
15. Lana Zhovtis Ryerson
16. Pranil Raut
17. Rosetta Pedotti
18. Kathleen Hawker
19. Catarina Raposo
20. Jessica Priest
21. Mark Cabatingan
22. Ryan C. Winger
23. Mark J. Mulligan
24. Michelle Krogsgaard
25. Gregg J. Silverman
This article has 1 evaluations Latest evaluation on Jan 12, 2022 Published on Jan 10, 2022

Previous Next